We could not find any results for:
Make sure your spelling is correct or try broadening your search.
WALTHAM, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...
WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...
WALTHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -7.04 | -27.0561106841 | 26.02 | 26.7 | 17.0885 | 285787 | 22.20943714 | CS |
4 | -6.045 | -24.1558441558 | 25.025 | 29.35 | 17.0885 | 248101 | 24.75725924 | CS |
12 | -2.52 | -11.7209302326 | 21.5 | 29.35 | 17.0885 | 350576 | 24.21355152 | CS |
26 | -2.52 | -11.7209302326 | 21.5 | 29.35 | 17.0885 | 350576 | 24.21355152 | CS |
52 | -2.52 | -11.7209302326 | 21.5 | 29.35 | 17.0885 | 350576 | 24.21355152 | CS |
156 | -2.52 | -11.7209302326 | 21.5 | 29.35 | 17.0885 | 350576 | 24.21355152 | CS |
260 | -2.52 | -11.7209302326 | 21.5 | 29.35 | 17.0885 | 350576 | 24.21355152 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions